Clinical Trials Insight: 700039184

Trial Profile

Clinical Trials Insight: 700039184

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 13 Jan 2010

At a glance

  • Drugs XY 4083 (Primary)
  • Indications Alzheimer's disease; Attention-deficit hyperactivity disorder; Cognition disorders; Schizophrenia
  • Focus Adverse reactions
  • Sponsors Xytis
  • Most Recent Events

    • 28 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top